Surratt CK - Search Results

1

Calmodulin regulation of basal and agonist-stimulated G protein coupling by the mu-opioid receptor (OP(3)) in morphine-pretreated cell.

Wang D, Surratt CK, Sadée W. Wang D, et al. Among authors: surratt ck. J Neurochem. 2000 Aug;75(2):763-71. doi: 10.1046/j.1471-4159.2000.0750763.x. J Neurochem. 2000. PMID: 10899953

2

Control of mu opioid receptor expression by modification of cDNA 5'- and 3'-noncoding regions.

Zöllner C, Johnson PS, Bei Wang J, Roy AJ Jr, Layton KM, Min Wu J, Surratt CK. Zöllner C, et al. Among authors: surratt ck. Brain Res Mol Brain Res. 2000 Jun 23;79(1-2):159-62. doi: 10.1016/s0169-328x(00)00100-5. Brain Res Mol Brain Res. 2000. PMID: 10925154

3

Role for the C-terminus in agonist-induced mu opioid receptor phosphorylation and desensitization.

Deng HB, Yu Y, Pak Y, O'Dowd BF, George SR, Surratt CK, Uhl GR, Wang JB. Deng HB, et al. Among authors: surratt ck. Biochemistry. 2000 May 9;39(18):5492-9. doi: 10.1021/bi991938b. Biochemistry. 2000. PMID: 10820022

4

beta-Funaltrexamine, a gauge for the recognition site of wildtype and mutant H297Q mu-opioid receptors.

Spivak CE, Beglan CL, Zöllner C, Surratt CK. Spivak CE, et al. Among authors: surratt ck. Synapse. 2003 Jul;49(1):55-60. doi: 10.1002/syn.10205. Synapse. 2003. PMID: 12710015

5

G protein-coupled receptor structural motifs: relevance to the opioid receptors.

Surratt CK, Adams WR. Surratt CK, et al. Curr Top Med Chem. 2005;5(3):315-24. doi: 10.2174/1568026053544533. Curr Top Med Chem. 2005. PMID: 15857314 Review.

6

Mutation of human mu opioid receptor extracellular "disulfide cysteine" residues alters ligand binding but does not prevent receptor targeting to the cell plasma membrane.

Zhang P, Johnson PS, Zöllner C, Wang W, Wang Z, Montes AE, Seidleck BK, Blaschak CJ, Surratt CK. Zhang P, et al. Among authors: surratt ck. Brain Res Mol Brain Res. 1999 Oct 1;72(2):195-204. doi: 10.1016/s0169-328x(99)00241-7. Brain Res Mol Brain Res. 1999. PMID: 10529478

7

Naloxone activation of mu-opioid receptors mutated at a histidine residue lining the opioid binding cavity.

Spivak CE, Beglan CL, Seidleck BK, Hirshbein LD, Blaschak CJ, Uhl GR, Surratt CK. Spivak CE, et al. Among authors: surratt ck. Mol Pharmacol. 1997 Dec;52(6):983-92. doi: 10.1124/mol.52.6.983. Mol Pharmacol. 1997. PMID: 9415708

8

-mu opiate receptor. Charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activity.

Surratt CK, Johnson PS, Moriwaki A, Seidleck BK, Blaschak CJ, Wang JB, Uhl GR. Surratt CK, et al. J Biol Chem. 1994 Aug 12;269(32):20548-53. J Biol Chem. 1994. PMID: 8051154

9

Dopamine transporter-dependent and -independent striatal binding of the benztropine analog JHW 007, a cocaine antagonist with low abuse liability.

Kopajtic TA, Liu Y, Surratt CK, Donovan DM, Newman AH, Katz JL. Kopajtic TA, et al. Among authors: surratt ck. J Pharmacol Exp Ther. 2010 Dec;335(3):703-14. doi: 10.1124/jpet.110.171629. Epub 2010 Sep 20. J Pharmacol Exp Ther. 2010. PMID: 20855444 Free PMC article.

10

Dopamine Transporter Dynamics of N-Substituted Benztropine Analogs with Atypical Behavioral Effects.

Hong WC, Wasko MJ, Wilkinson DS, Hiranita T, Li L, Hayashi S, Snell DB, Madura JD, Surratt CK, Katz JL. Hong WC, et al. Among authors: surratt ck. J Pharmacol Exp Ther. 2018 Sep;366(3):527-540. doi: 10.1124/jpet.118.250498. Epub 2018 Jun 26. J Pharmacol Exp Ther. 2018. PMID: 29945932 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results